Dr. Sylvie GrÃ©goire, President of Shire Human Genetic Therapies, presented at last year's World Orphan Drug Congress USA on the topic â€˜The social responsibility of companies working with orphan diseases.'
Do you want to learn more about:
- Differentiating the orphan drug market from the traditional pharma market
- Focusing on patients and personalized marketing: a paradigm shift to market drugs in orphan diseases
- Industry’s responsibility to provide patients with access to orphan drugs
If so, you need to check out the video below: